News stories, service updates, and other important messages.
A new spin-out company from the Universities of Bath and Edinburgh has launched with a mission to enable lung cancer biopsy and treatment in a single visit.
Bath embryologists find that after fertilisation, mouse embryo genes are switched on in a pre-set order and that the triggers responsible are linked to cancer.
Research validates an imaging platform co-developed at CTI-Bath which predicts if a cancer patient would respond well to immunotherapy.
Dr Ute Jungwirth from the Department of Pharmacy & Pharmacology is the new chair of Cancer Research at Bath and she has plans for a September in-person event.
Scientists at the University of Bath have developed a new technique to accelerate the discovery of drugs that shut down proteins known to cause cancer.
Bath researchers collaborate with Sapience Therapeutics to find new treatments for cancer cell targets that don't respond to other drugs.
A new prognostic tool developed by an international team led by CTI-Bath paves the way for personalised medicine for cancer patients.
A molecule that suppresses melanoma tumours has been identified at the University of Bath
Scientists screened tens of thousands of molecules looking for those with anti-cancer potential.
The drugs are up to 20 times more effective than existing drugs targeting the AMACR protein.